Microscopy Core Facility Visualization of tissues, cells, viruses and molecules by microscopy is essential for probing concepts and creating new avenues of cancer research. Techniques have evolved over the past decade that have expanded the utility of both light and electron microscopy to interrogate cells at all levels. The UNC LCCC Microscopy Core has continued to evolve over the last cycle upgrading instrumentation in its highly utilized Light Microscopy component and in its Electron Microscopy component, as well as adding major instrumentation in intravital microscopy. Substantial utilization of the first component and more specialized use of electron microscopy have resulted in an outstanding publication record. This combined core offers LCCC members access to state-of-the art service in light microscopy together with research-based ElVI and intravital imaging. While the core grant provides only a small fraction of the total operational costs, this key contribution makes it possible to provide access to the instruments, training, and staff at little to no cost to LCCC members. As a result, the core has had a major impact on the cancer-related research of the LCCC. Multiple publications from the core over the past six years include papers in Cell, PNAS and Nature. New instrumentation obtained by the Core represented an investment of nearly $3,000,000 including significant upgrades for cryoEM to for the EM core, new CLSM and wide field instruments for the light microscopy facility, and a multiphoton microscope for intravital work. Over 60 LCCC members in eight programs used the Core during 2009. One highlight of the light microscopy core over the coming five years will be the addition of bio-sensor imaging methods in collaboration with Dr Klaus Hahn to probe key signaling pathways and to advance multi-spectral confocal imaging involving five or more colored indicators. The EM core will be bringing new cryoEM methods to the LCCC faculty and the intravital capability will allow investigators to study tumor and stromal cells inside of live animals. The Microscopy Core requests $212,590 in CCSG representing 39% of operating costs for 2010. Last year 87% of the core usage was by center members. A significant increase in the budget is proposed to make available expansion of existing services and access to a number of new microscopes and techniques added in the past two years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-35
Application #
8340303
Study Section
Subcommittee G - Education (NCI)
Project Start
2011-05-23
Project End
2015-11-30
Budget Start
2011-05-23
Budget End
2011-11-30
Support Year
35
Fiscal Year
2011
Total Cost
$263,060
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Moschos, Stergios J; Sullivan, Ryan J; Hwu, Wen-Jen et al. (2018) Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight 3:
Brosnan, Evelyn M; Anders, Carey K (2018) Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med 6:163
Valle, Carmina G; Queen, Tara L; Martin, Barbara A et al. (2018) Optimizing Tailored Communications for Health Risk Assessment: A Randomized Factorial Experiment of the Effects of Expectancy Priming, Autonomy Support, and Exemplification. J Med Internet Res 20:e63
Sun, Junjiang; Shao, Wenwei; Chen, Xiaojing et al. (2018) An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 10:257-267
Wilczewski, Caralynn M; Hepperla, Austin J; Shimbo, Takashi et al. (2018) CHD4 and the NuRD complex directly control cardiac sarcomere formation. Proc Natl Acad Sci U S A 115:6727-6732
Waters, Andrew M; Der, Channing J (2018) KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. Cold Spring Harb Perspect Med 8:
Gralinski, Lisa E; Sheahan, Timothy P; Morrison, Thomas E et al. (2018) Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. MBio 9:
Au, Kin Man; Tripathy, Ashutosh; Lin, Carolina Pe-I et al. (2018) Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma. ACS Nano 12:1544-1563
Mirlekar, Bhalchandra; Michaud, Daniel; Searcy, Ryan et al. (2018) IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. Cancer Immunol Res 6:1014-1024

Showing the most recent 10 out of 1525 publications